SOURCE: Street-Wire.Com

November 01, 2012 09:37 ET

Financial Review on Healthcare Stocks Forest Laboratories Inc. and Endo Health Solutions Inc. -- Drug Manufacturers Focusing on Expansion and Litigation

NEW DELHI, INDIA--(Marketwire - Nov 1, 2012) - The drug manufacturers -- other industry, which features companies such as Forest Laboratories Inc. and Endo Health Solutions Inc., has been operating under complex conditions as of late. Patent expirations continue to negatively impact financials while research and development remains costly and time consuming. The Drug Manufacturers - Other industry has seen the above updates lately. And members can today access complimentary reports for two companies, Forest Laboratories Inc. (NYSE: FRX) and Endo Health Solutions Inc. (NASDAQ: ENDP), serving this industry by following this link has brought together some of the best financial and technical minds from around the biggest economies globally so that you can have an array of free stock research and reporting. As the global economy continues to experience colossal strain and unprecedented actions are been taken by governments and the private sectors to survive and boost the dwindling worldwide economic growth, our researchers give you insight of how big players in different key sectors and industries of the American exchanges are faring. Sign up now for your free membership at

On the legal side of things, battles over patent infringement cases have led some companies higher while others have been dealt major setbacks. Settlement agreements have been popular, though the ultimate problem of loss of exclusivity is still a concern. Forest Laboratories Inc. financial analysis available by signing up for free at 

To counter some of the aforementioned headwinds, several companies in the industry have been expanding their operations abroad. Europe and Asia have been popular expansion destinations, though Latin America is also gaining in popularity. A number of companies have entered into strategic alliances with foreign companies that are already established abroad, which should make it easier for them to grow moving forward. posted financial analysis on Endo Health Solutions Inc. today, members can access it at 

Getting the necessary approvals for their products is another story though, and drug manufacturers that are able to team-up with foreign businesses while also getting their products to market could be best positioned.

About Street-Wire:

Street-Wire aims to satisfy our new members with timely knowledge and to provide veteran traders with innovative and cognitive content when it comes to investing. We believe learning is a two-way channel, and we learn from our members as much as we provide them with what they need to make sense of the markets. We strive to introduce investors to new analytical viewpoint before the market becomes aware of them. 

Read our Disclaimer

Contact Information